DarioHealth Corp. announced two new contracts to provide its highly personalized digital therapeutics beginning in the first quarter of 2022. The new clients include a large Northeast regional employer in the finance industry set to deploy Dario's full suite of solutions, and a Northeast regional employer in the food industry contracted to deploy Dario's digital therapeutic solution for diabetes.

Dario's digital therapeutics platform provides highly personalized support for people living with diabetes, pre-diabetes, hypertension, weight management, musculoskeletal and behavioral health needs through a combination of innovative technologies, digital tools and expert human support. Full integration across a single AI-driven behavior change engine addresses the underlying health behaviors using intelligence gathered from billions of data points collected over ten years of consumer engagement to create a holistic, seamless member experience proven to deliver sustainable engagement and results.